Stratifying risk for multiple, recurrent, and large (>/=3 cm) Ta, G1/G2 tumors in non-muscle-invasive bladder cancer. Suh J, Jung JH, Kwak C, Kim HH, et al. Investig Clin Urol 2021;62:408-415.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Suh J, Jung JH, Kwak C, Kim HH, et al. Stratifying risk for multiple, recurrent, and large (>/=3 cm) Ta, G1/G2 tumors in non-muscle-invasive bladder cancer. Investig Clin Urol 2021;62:408-415.
PMID: 34190435